BR9608571A - Compostos anti-virais - Google Patents

Compostos anti-virais

Info

Publication number
BR9608571A
BR9608571A BR9608571A BR9608571A BR9608571A BR 9608571 A BR9608571 A BR 9608571A BR 9608571 A BR9608571 A BR 9608571A BR 9608571 A BR9608571 A BR 9608571A BR 9608571 A BR9608571 A BR 9608571A
Authority
BR
Brazil
Prior art keywords
viral compounds
viral
compounds
Prior art date
Application number
BR9608571A
Other languages
English (en)
Inventor
Shawn Christopher Miller
Thomas R Senior Sattelberg
Mark Joseph Tebbe
Frantz Victor
Wayne Alfred Spitzer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9608571A publication Critical patent/BR9608571A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9608571A 1995-06-07 1996-06-05 Compostos anti-virais BR9608571A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,041 US5545653A (en) 1995-06-07 1995-06-07 Anti-viral compounds
PCT/US1996/008830 WO1996040124A1 (en) 1995-06-07 1996-06-05 Anti-viral compounds

Publications (1)

Publication Number Publication Date
BR9608571A true BR9608571A (pt) 1998-12-29

Family

ID=23914403

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608571A BR9608571A (pt) 1995-06-07 1996-06-05 Compostos anti-virais

Country Status (10)

Country Link
US (1) US5545653A (pt)
EP (1) EP0862430A4 (pt)
JP (1) JPH11506772A (pt)
KR (1) KR19990022363A (pt)
AU (1) AU5982496A (pt)
BR (1) BR9608571A (pt)
CA (1) CA2223299A1 (pt)
HU (1) HUP9900865A3 (pt)
IL (1) IL122377A (pt)
WO (1) WO1996040124A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
AU741772B2 (en) 1997-02-25 2001-12-06 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
EP1001767A4 (en) * 1997-06-04 2001-07-04 Lilly Co Eli ANTIVIRAL CONNECTIONS
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6699705B2 (en) 1999-02-01 2004-03-02 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
AU2003294249A1 (en) * 2002-11-08 2004-06-03 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
AR046971A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
EP1711496A4 (en) * 2004-01-28 2009-02-11 Smithkline Beecham Corp THIAZOLE COMPOUNDS
WO2009143571A1 (en) * 2008-05-27 2009-12-03 Biota Scientific Management Pty Ltd Antiviral salts
CN104394835B (zh) 2012-07-13 2018-09-07 莱雅公司 化妆品组合物
BR112020002674A2 (pt) * 2017-08-07 2020-07-28 Joint Stock Company Biocad compostos heterocíclicos inovadores como inibidores de cdk8/19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR61627B (en) * 1975-08-28 1978-12-04 Lilly Co Eli Preparation process of carbonyl-substituted 1-sulfonylbenzimidazoles
US4174454A (en) * 1975-08-28 1979-11-13 Eli Lilly And Company Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles
US4434288A (en) * 1982-04-08 1984-02-28 Eli Lilly And Company Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles
US4420479A (en) * 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles

Also Published As

Publication number Publication date
HUP9900865A3 (en) 2000-02-28
HUP9900865A2 (hu) 1999-07-28
US5545653A (en) 1996-08-13
WO1996040124A1 (en) 1996-12-19
EP0862430A1 (en) 1998-09-09
IL122377A0 (en) 1998-06-15
CA2223299A1 (en) 1996-12-19
JPH11506772A (ja) 1999-06-15
EP0862430A4 (en) 1999-03-24
IL122377A (en) 2001-01-11
AU5982496A (en) 1996-12-30
KR19990022363A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
ID16345A (id) Senyawa-senyawa heterosiklik
ATE258166T1 (de) Substituierte benzylaminpiperidin-verbindungen
BR9609682A (pt) Foto-desinfetantes de baixa nuança
DE69608259D1 (de) Verbunddamenbinde
DE59609887D1 (de) Substituierte cyanophenyluracile
BR9600251A (pt) Composto
NO982566D0 (no) Forbindelser
BR9608571A (pt) Compostos anti-virais
ATA135896A (de) Skibob
NO974170D0 (no) Polyazacykloalkan-forbindelser
DE59610332D1 (de) Substituierte aminouracile
BR9601295A (pt) Composto
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
BR9611576A (pt) Composto
ATE198470T1 (de) Alkenyl-benzoylguanidine
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
PT839024E (pt) Formulacoes de monensina
DE59607732D1 (de) Substituierte benzylidencyanessigester
ID18956A (id) Senyawa-senyawa herbisida
DE59607958D1 (de) Substituierte phenyluracile
DE59600405D1 (de) Gehhilfe
DE29508891U1 (de) Popads
FIU950291U0 (fi) Laegereldstomme
BR1100842A (pt) Compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]